Pfizer Other Non-Current Liabilities 2010-2024 | PFE

Pfizer other non-current liabilities for the quarter ending September 30, 2024 were $21.474B, a 3.88% decline year-over-year.

  • Pfizer other non-current liabilities for 2023 were $25.073B, a 9.05% increase from 2022.
  • Pfizer other non-current liabilities for 2022 were $22.992B, a 9.1% increase from 2021.
  • Pfizer other non-current liabilities for 2021 were $21.074B, a 15.61% increase from 2020.

Pfizer Other Non-Current Liabilities 2010-2024 | PFE

  • Pfizer other non-current liabilities for 2023 were $25.073B, a 9.05% increase from 2022.
  • Pfizer other non-current liabilities for 2022 were $22.992B, a 9.1% increase from 2021.
  • Pfizer other non-current liabilities for 2021 were $21.074B, a 15.61% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B